Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
10.75
+0.77 (7.72%)
At close: Apr 28, 2026, 4:00 PM EDT
10.74
-0.01 (-0.09%)
After-hours: Apr 28, 2026, 7:14 PM EDT
Immunic Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Immunic stock have an average target of 45, with a low estimate of 25 and a high estimate of 70. The average target predicts an increase of 318.60% from the current stock price of 10.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunic stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +132.56% | Apr 17, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 15, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +551.16% | Mar 24, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $50 | Strong Buy | Maintains | $80 → $50 | +365.12% | Mar 2, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $80 → $40 | Strong Buy | Maintains | $80 → $40 | +272.09% | Feb 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
13.16M
EPS This Year
-0.38
from -6.24
EPS Next Year
-0.31
from -0.38
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 94.8M | ||||||
| Avg | n/a | 13.2M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.19 | -0.09 | ||||||
| Avg | -0.38 | -0.31 | ||||||
| Low | -0.63 | -0.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.